Stereotactic ablative radiation therapy for subcentimeter lung tumors: Clinical, dosimetric, and image guidance considerations

International Journal of Radiation Oncology Biology Physics

Volumn 90, Issue 4, 2014, Pages 843-849

  Louie, Alexander V ^a,b,c   Senan, Suresh ^a   Dahele, Max ^a   Slotman, Ben J ^a   Verbakel, Wilko F A R ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; DOSIMETRY; RADIOTHERAPY; TUMORS; VISIBILITY;

ANALYTIC ALGORITHM; CONE-BEAM COMPUTED TOMOGRAPHY; INTERNAL TARGET VOLUME; KAPLAN-MEIER METHOD; METHODS AND MATERIALS; OVERALL SURVIVAL RATES; PLANNING TARGET VOLUMES; PROGRESSION FREE SURVIVAL;

COMPUTERIZED TOMOGRAPHY;

ALGORITHM; ARTICLE; ARTIFACT; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONE BEAM COMPUTED TOMOGRAPHY; DOSIMETRY; FEMALE; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HUMAN; KAPLAN MEIER METHOD; LUNG TUMOR; MALE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; STEREOTACTIC ABLATIVE RADIATION THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME; BREATHING; COMPUTER ASSISTED RADIOTHERAPY; IMAGE GUIDED RADIOTHERAPY; LUNG NEOPLASMS; PATHOLOGY; PROCEDURES; RADIATION DOSE; RADIOGRAPHY; RADIOSURGERY; RETROSPECTIVE STUDY;

ALGORITHMS; CONE-BEAM COMPUTED TOMOGRAPHY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RESPIRATION; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 84908212692     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.06.064     Document Type: Article

References (38)

1. R. Siegel, J. Ma, and Z. Zou Cancer statistics, 2014 CA Cancer J Clin 64 2014 9 29
2. National Lung Screening Trial Research Team D.R. Aberle, A.M. Adams, and C.D. Berg Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 2011 395 409
3. S.A. Kovalchik, M. Tammemagi, and C.D. Berg Targeting of low-dose CT screening according to the risk of lung-cancer death N Engl J Med 369 2013 245 254
4. D. Hamatake, Y. Yoshida, and S. Miyahara Surgical outcomes of lung cancer measuring less than 1 cm in diameter Interact Cardiovasc Thorac Surg 15 2012 854 858
5. M.J. Schuchert, A. Kilic, and A. Pennathur Oncologic outcomes after surgical resection of subcentimeter non-small cell lung cancer Ann Thorac Surg 91 2011 1681 1688 discussion 1687-1688
6. S. Senan, M.A. Paul, and F.J. Lagerwaard Treatment of early-stage lung cancer detected by screening: Surgery or stereotactic ablative radiotherapy? Lancet Oncol 14 2013 e270 e274
7. J. Vansteenkiste, D. De Ruysscher, and W.E. Eberhardt Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 24 suppl 6 2013 vi89 vi98
8. J. Donington, M. Ferguson, and P. Mazzone American college of chest physicians and society of thoracic surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer Chest 142 2012 1620 1635
9. A. Chi, Z. Liao, and N.P. Nguyen Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications Radiother Oncol 94 2010 1 11
10. T. Knoos, E. Wieslander, and L. Cozzi Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations Phys Med Biol 51 2006 5785 5807
11. L.R. Aarup, A.E. Nahum, and C. Zacharatou The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: Implications for tumour coverage Radiother Oncol 91 2009 405 414
12. K. Bush, I.M. Gagne, and S. Zavgorodni Dosimetric validation of Acuros XB with Monte Carlo methods for photon dose calculations Med Phys 38 2011 2208 2221
13. O.N. Vassiliev, T.A. Wareing, and J. McGhee Validation of a new grid-based Boltzmann equation solver for dose calculation in radiotherapy with photon beams Phys Med Biol 55 2010 581 598
14. F.J. Lagerwaard, C.J. Haasbeek, and E.F. Smit Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
15. C.W. Hurkmans, J.P. Cuijpers, and F.J. Lagerwaard Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: Report from the quality assurance working party of the randomised phase III Rosel study Radiat Oncol 4 2009 1
16. M. Koto, T. Miyamoto, and N. Yamamoto Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy Radiother Oncol 71 2004 147 156
17. S. Rana, K. Rogers, and S. Pokharel Evaluation of Acuros XB algorithm based on RTOG 0813 dosimetric criteria for SBRT lung treatment with Rapidarc J Appl Clin Med Phys 15 2014 4474
18. P.S. Kroon, S. Hol, and M. Essers Dosimetric accuracy and clinical quality of Acuros XB and AAA dose calculation algorithm for stereotactic and conventional lung volumetric modulated arc therapy plans Radiat Oncol 8 2013 149
19. H.W. Liu, Z. Nugent, and R. Clayton Clinical impact of using the deterministic patient dose calculation algorithm Acuros XB for lung stereotactic body radiation therapy Acta Oncol 53 2014 324 329
20. Y. Tsutani, Y. Miyata, and H. Nakayama Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage Ia lung adenocarcinoma: Wedge resection or segmentectomy Chest 145 2014 66 71
21. D.P. Naidich, A.A. Bankier, and H. MacMahon Recommendations for the management of subsolid pulmonary nodules detected at CT: A statement from the Fleischner Society Radiology 266 2013 304 317
22. D. Urban, M. Mishra, and A. Onn Radiotherapy improves survival in unresected stage I-III bronchoalveolar carcinoma Int J Radiat Oncol Biol Phys 84 2012 780 785
23. K. Latifi, J. Oliver, and R. Baker Study of 201 non-small cell lung cancer patients given stereotactic ablative radiation therapy shows local control dependence on dose calculation algorithm Int J Radiat Oncol Biol Phys 88 2014 1108 1113
24. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (hypofxsrt) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 100
25. S. Senthi, C.J. Haasbeek, and B.J. Slotman Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic review Radiother Oncol 106 2013 276 282
26. D.A. Palma, and S. Senan Early-stage non-small cell lung cancer in elderly patients: Should stereotactic radiation therapy be the standard of care? Int J Radiat Oncol Biol Phys 84 2012 1058 1059
27. J.R. Olsen, C.G. Robinson, and I. El Naqa Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer Int J Radiat Oncol Biol Phys 81 2011 e299 303
28. H. MacMahon, J.H. Austin, and G. Gamsu Guidelines for management of small pulmonary nodules detected on CT scans: A statement from the Fleischer Society Radiology 237 2005 395 400
29. A.V. Louie Senthi S Palma DA. Surgery versus SABR for NSCLC Lancet Oncol 14 2013 e491
30. M.K. Gould, J. Donington, and W.R. Lynch Evaluation of individuals with pulmonary nodules: When is it lung cancer? Diagnosis and management of lung cancer, 3rd edition: American College of Chest Physicians evidence-based clinical practice guidelines Chest 143 2013 e93S e120S
31. T. Treasure, M. Milosevic, F. Fiorentino, and F. Macbeth Pulmonary metastasectomy: What is the practice and where is the evidence for effectiveness? Thorax 69 2014 946 949
32. J. Widder, T.J. Klinkenberg, and J.F. Ubbels Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy? Radiother Oncol 107 2013 409 413
33. E. Kuo, A. Bharat, and N. Bontumasi Impact of video-assisted thoracoscopic surgery on benign resections for solitary pulmonary nodules Ann Thorac Surg 93 2012 266 272 discussion 272-273
34. G.J. Herder, H. Kramer, and O.S. Hoekstra Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: A Dutch cooperative randomized study J Clin Oncol 24 2006 1800 1806
35. H. van Tinteren, O.S. Hoekstra, and E.F. Smit Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: The Plus Multicentre Randomised Trial Lancet 359 2002 1388 1393
36. N.E. Verstegen, J.W. Oosterhuis, and D.A. Palma Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): Outcomes of a propensity score-matched analysis Ann Oncol 24 2013 1543 1548
37. H.J. Mehta, J.G. Ravenel, and S.R. Shaftman The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules Chest 145 2014 464 472
38. J.J. Ojala, M.K. Kapanen, and S.J. Hyodynmaa Performance of dose calculation algorithms from three generations in lung SBRT: Comparison with full Monte Carlo-based dose distributions J Appl Clin Med Phys 15 2014 4662